Replies to post #763770 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Tomorrow is the last CHM meeting for April, If nothing from that meeting then Im downgrading the MHRA review on DCVAXL to semi-junk status.

[FeMike]

Why do you think it’ll take that long? If there’s a strong reason behind it, please do share—I’m genuinely curious.

It’s not a “strong reason” I’m not going to claim that.

I just consider myself extremely in tune with the tone of NWBO disclosures. I don’t agree with most of the stuff they do, but I think I still understand how they think.

I strongly believe that the only reason to include their decision to not attend ASCO (which starts at the very end of May) in favor of working on the application was to signal to investors that they were still expecting the MAA decision to take a bit longer (ASCO timeframe).

My best guess is that they know this PIP ordeal had a significant impact on the timeline.